| Cancer site | Total | Men | Women | ||||||
|---|---|---|---|---|---|---|---|---|---|
| No. of observed cases | No. of excess attributable cases* | % attributable† | No. of observed cases | No. of excess attributable cases | % attributable | No. of observed cases | No. of excess attributable cases | % attributable | |
| Esophagus‡ | 123 | 38 | 30.9 | 110 | 35 | 31.8 | 13 | 3 | 23.1 |
| Pancreas | 380 | 25 | 6.6 | 172 | 9 | 5.2 | 208 | 16 | 7.7 |
| Colorectum | 1955 | 239 | 12.2 | 1107 | 191 | 17.2 | 848 | 48 | 5.7 |
| Kidney | 482 | 83 | 17.2 | 326 | 54 | 16.6 | 156 | 29 | 18.6 |
| Breast§ | 1545 | 124 | 8.0 | - | - | - | 1545 | 124 | 8.0 |
| Endometrium | 504 | 153 | 30.4 | - | - | - | 504 | 153 | 30.4 |
| Gall bladder | 55 | 11 | 20.0 | 24 | 2 | 6.5 | 31 | 10 | 32.2 |
| All associated cancers¶ | 5044 | 673 | 13.3 | 1739 | 290 | 16.7 | 3305 | 383 | 11.6 |
| All cancers** | 15 836 | 673 | 4.2 | 8155 | 290 | 3.6 | 7681 | 383 | 5.0 |
*Number of cancer cases at individual cancer sites that can be attributed to overweight/obesity.
†Proportion of cancers at individual cancer sites attributable to overweight/obesity.
‡Adenocarcinomas only.
§In postmenopausal women only (defined as cancers diagnosed at age 55 or more).
¶Represents all cancers with a known association with overweight/obesity, as listed in table.
**Represents all incident cancers in Alberta in 2012 in all age groups.